Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
Efficacy of Immunonutrition in Improving Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Listed as NCT04611113, this NA trial focuses on Head and Neck Cancer and remains actively recruiting participants. Sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia, it has been updated 9 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Recruiting NA
Status: Unknown → Recruiting
-
Sep 2024 — Jun 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2022 — Jun 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Apr 2021 — Jun 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione IRCCS Policlinico San Matteo di Pavia
For direct contact, visit the study record on ClinicalTrials.gov .